OutSee: Venture Capital Funding History
OutSee
To add a bio or update company history, please click update information.
News from OutSee


OutSee
24 Jun 2025
OutSee raises £1.8m seed round led by Ahren Innovation Capital to advance AI-driven genomic target discovery
OutSee builds a predictive genomics platform that uses hypothesis-free AI modelling to discover new therapeutic targets, supporting precision medicine across neurological, rare and metabolic diseases.


OutSee
12 Jan 2026
OutSee completes its £2.5m seed round led by Ahren Innovation Capital for its genomic drug discovery platform
OutSee develops AI-driven genomics software that identifies disease targets directly from genetic data, supporting drug discovery by uncovering biological mechanisms missed by conventional analysis methods.
OutSee
- Life Sciences
- Cambridge, United Kingdom
- £4.3m
- outsee.co.uk
- Update Information
More venture news
- 13 Nov 2026

Oyster TherapeuticsOyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
Series ALife Sciences - 10 Nov 2026

Neobe TherapeuticsNeobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours
SeedLife Sciences - 9 Nov 2026

PhaSER BiomedicalPhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases
GrantLife Sciences